Vision Therapy Versus Prism Treatment in Small-angle Acute Acquired Concomitant Esotropia

NCT ID: NCT06622044

Last Updated: 2025-12-09

Basic Information

• Recruitment Status: RECRUITING
• Clinical Phase: NA
• Total Enrollment: 100 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2024-09-07
• Study Completion Date: 2026-12-07

Brief Summary

This is a single-center, randomized controlled clinical trial to compare the effectiveness of vision therapy and prism wearing for the treatment of small-angle acute acquired concomitant esotropia.

Detailed Description

Acute acquired concomitant esotropia (AACE) belongs to the category of concomitant strabismus. It is characterized by sudden onset, often accompanied by diplopia, and no change in the strabismus angle of each eye position. In recent years, with the increase in the use of smartphones and other screen devices, the incidence of AACE has been on the rise. Commonly used treatments in clinical practice include surgical treatment, botulinum toxin injection into the medial rectus muscle, and prism treatment. Patients with large-angle esotropia generally require surgical intervention to fundamentally correct patients eye positions and eliminate diplopia. However, surgical treatment requires waiting for six months in order to performed after the strabismus degree is stable. There are also risks of intraoperative trauma and secondary surgery. Patients with early and small-angle esotropia often choose prism treatment.

The principle of prism treatment is light refraction. After light is refracted through a prism, it falls on the fovea of the strabismic eye, eliminating diplopia. In the treatment of AACE, the main target population of prisms is patients with mild strabismus (the strabismus angle is usually less than 25 PD). Wearing prisms can eliminate diplopia and relieve related symptoms, but it does not really correct the strabismus problem.

The high incidence of AACE is related to excessive close work and use of electronic products. Excessive close eye use can lead to accommodative dysfunction. Studies have found that AACE patients have abnormal accommodative function. The accommodative function of AACE patients is weaker than normal, and the accommodation convergence to accommodation (AC/A) ratio is higher than normal. During clinical diagnosis and treatment, the accommodative function of AACE patients was examined and it was found that there was indeed abnormal accommodative function. Based on scientific research findings and the actual basis of clinical practice, improving accommodative function through accommodative training may be a good treatment option for early and small-angle AACE patients. However, existing studies have not fully explored the effectiveness and safety of accommodative exercise in the treatment of small-angle AACE, and there has been no study comparing the therapeutic outcomes of accommodative training and prism treatment on small-angle AACE.

In order to better guide clinical practice, we conducted a randomized controlled study to objectively evaluate and compare the therapeutic effects of accommodative training and prism therapy on AACE. It is expected that the research results will provide more treatment options for AACE patients and provide important guidance for clinical selection of appropriate methods to treat small-angle AACE.

Conditions

Esotropia

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: SINGLE

Study Groups

Vision therapy group

Accommodation facility exercises and divergence exercises

Group Type: EXPERIMENTAL

Vision therapy group

Intervention Type: OTHER

accommodation and vergence exercise

Prism group

wearing prism glasses

Group Type: ACTIVE_COMPARATOR

Prism

Intervention Type: OTHER

wearing prism glasses

Interventions

Vision therapy group

accommodation and vergence exercise

Intervention Type: OTHER

Prism

wearing prism glasses

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

1. Aged 10-40 years (including 10 years and 40 years);

2. Best-corrected visual acuity no worse than 20/20 for both eyes;

3. Deviation angle less than 15 prism diopters (including 15 prism diopters);

Exclusion Criteria

1. Organic eye diseases;

2. Lesions of the brain;

3. Receiving esotropia therapy(including surgery and prism treatment)

4. Devation angle reducing more than 10 prism diopters after refractive correction

• Minimum Eligible Age: 10 Years
• Maximum Eligible Age: 40 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Eye & ENT Hospital of Fudan University

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

Eye & ENT Hospital of Fudan University

Shanghai, , China

Site Status: RECRUITING

Countries

China

Central Contacts

Wen Wen, MD, PhD

Role: CONTACT

wenweneye@126.com

+86 (21) 3423 3133

Shuyang Guo, MD

Role: CONTACT

m15880091363@163.com

Other Identifiers

2024-ATAACE

Identifier Type: -

Identifier Source: org_study_id